LIFETECH SCI (01302) issues a profit warning, expecting a loss attributable to shareholders of 30 million to 40 million yuan for the first half of the year.

LIFETECH SCI (01302) announced that after excluding several non-recurring items as described below, the Group expects to achieve a profit attributable to shareholders of between RMB 110 million and RMB 120 million for the six months ending June 30, 2026, compared to approximately RMB 238.5 million for the same period in 2025. The decrease is primarily due to a decline in revenue and a significant reduction in net foreign exchange gains. The non-recurring items include share-based payment expenses, other gains and losses on financial assets measured at fair value through profit or loss, and expected transaction costs related to the acquisition of equity in Beijing Huayi Shengjie Technology Co., Ltd. and the issuance of convertible bonds, which the Board has resolved not to proceed with. Considering the impact of these non-recurring items, the Group expects to incur a loss attributable to shareholders of between RMB 30 million and RMB 40 million for the six months ending June 30, 2026, compared to a profit attributable to shareholders of approximately RMB 55.1 million for the same period in 2025.